Case number 1:19-cv-01885
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 28, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per the filing of the Consent Judgment in Lead Case No. 18-1689-CFC. (nmf) |
| Oct 29, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01689-CFC-SRF. (fms) |
| Oct 29, 2019 | N/A | Remark (0) Docket Text: All papers shall be filed in C.A. No. 18-1689 (CFC) (consolidated). Associated Cases: 1:18-cv-01689-CFC-SRF et al.(fms) |
| Oct 29, 2019 | 9 | SO ORDERED (6) Docket Text: SO ORDERED, re (8 in 1:19-cv-01866-CFC, 8 in 1:19-cv-01865-CFC, 8 in 1:19-cv-01885-CFC, 8 in 1:19-cv-01864-CFC, 127 in 1:18-cv-01689-CFC-SRF, 9 in 1:19-cv-01862-CFC) Stipulation. The New Cases shall be consolidated with the Consolidated Action for all purposes, and all papers shall be filed in C.A. No. 18-1689 (CFC) (consolidated). See Stipulations for further details and deadlines. Signed by Judge Colm F. Connolly on 10/29/2019. Associated Cases: 1:18-cv-01689-CFC-SRF et al.(fms) |
| Oct 21, 2019 | 8 | Stipulation (6) Docket Text: STIPULATION for Consolidation by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) |
| Oct 14, 2019 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Alembic Pharmaceuticals Ltd. served on 10/14/2019, answer due 11/4/2019. (Egan, Brian) |
| Oct 14, 2019 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Alembic Pharmaceuticals, Inc. served on 10/14/2019, answer due 11/4/2019. (Egan, Brian) |
| Oct 9, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:19-cv-01862-CFC, 1:19-cv-01864-CFC, 1:19-cv-01865-CFC, 1:19-cv-01866-CFC, 1:19-cv-01885-CFC (rjb) |
| Oct 8, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alembic Pharmaceuticals Ltd. on 10/8/2019; Alembic Pharmaceuticals, Inc. on 10/8/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Oct 7, 2019 | 1 | Exhibit 1 (48) |
| Oct 7, 2019 | 1 | Civil Cover Sheet (1) |
| Oct 7, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Oct 7, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/26/2019. Date of Expiration of Patent: 4/3/2034.Thirty Month Stay Deadline: 2/1/2022. (lak) |
| Oct 7, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,258,637 B2. (lak) |
| Oct 7, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (lak) |
